INSIGHTS ON DRUG DEVELOPMENT

• Three Keys To E&L Success: Study Design, Partner Selection, And Timing

  Successful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.

• Chemoenzymatic N-glycan Conjugation Of Native mAbs Provides Homogeneous, Efficacious ADCs

  A chemoenzymatic two-stage protocol enables DAR2 ADCs from native, non-engineered mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable marketed ADC.

• How Organ-Chips Are Transforming Women's Reproductive Health Research

  Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

• Are You Keeping Pace With Oligo Synthesis Optimization?

  The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  11/7/2025

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives

  3/11/2026

  By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  11/3/2025

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• CDMOs - Key Collaborators In Streamlining Drug Development

  12/12/2025

  Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

• A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics

  11/7/2025

  Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.